FTI
NVS icon

Fiduciary Trust International’s Novartis NVS Stock Holding History

Fiduciary Trust International’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-67
Closed -$5K – 439
2018
Q4 		$5K Buy
+67
New +$5.21K ﹤0.01% 431

Other funds holding NVS

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fiduciary Trust International's NVS Position: Q1 2019 in Review

Fiduciary Trust International sold out of Novartis (NVS) in Q1 2019, closing a stake of 67 shares — an estimated $5K sold.

Fiduciary Trust International first reported a position in NVS in Q4 2018 and held it in 1 quarter. The position peaked at $5K in Q4 2018. 1,133 funds tracked by Wall St. Rank hold NVS as of Q1 2019.

  • Fiduciary Trust International reported no remaining Novartis position as of Q1 2019 after selling out during the quarter.
  • Fiduciary Trust International sold 67 Novartis shares in Q1 2019, an estimated $5K.
  • Fiduciary Trust International first reported a position in Novartis in Q4 2018 and held it in 1 quarter.
  • Fiduciary Trust International's Novartis position peaked at $5K in Q4 2018.
  • 1,133 funds tracked by Wall St. Rank held Novartis as of Q1 2019.

Based on Fiduciary Trust International's 13F filing for Q1 2019, filed 7 May 2019.